Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Natl Med Assoc ; 96(11): 1499-502, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15586654

RESUMO

Kawasaki disease, also known as mucocutaneous lymph node syndrome, is a multisystem disease. It usually affects children below the age of five, but it occasionally affects adults. There are less than 50 English-reported adult cases in the literature, and only five reported cases of Kawasaki disease and pregnancy, as of 2003. The cases associated with pregnancy involved patients who had a history of Kawasaki disease during childhood and addressed how the complications of the illness (i.e,. coronary artery aneurysms) were managed during pregnancy and delivery. There are no reported cases of Kawasaki disease in postpartum patients. This article presents a case of Kawasaki disease in a 21-year-old, four-week postpartum patient who initially responded to intravenous (IV) antibiotic therapy. This paper will review the diagnosis and treatment of Kawasaki disease as well as the multiple outside variables that impact the management of adult postpartum patients with Kawasaki disease.


Assuntos
Síndrome de Linfonodos Mucocutâneos/diagnóstico , Período Pós-Parto , Doença Aguda , Adulto , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Aspirina/uso terapêutico , Feminino , Humanos , Síndrome de Linfonodos Mucocutâneos/tratamento farmacológico , Gravidez , Fatores de Risco
4.
J Asthma ; 42(6): 499-505, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16293546

RESUMO

To assess the effectiveness of an intervention designed to increase compliance with national asthma care guidelines in primary care safety net health centers serving high-disparity patient populations, we conducted a group-randomized controlled trial (seven intervention sites and nine control sites) in federally funded community health centers in eight southeastern states. There were three components involved in the intervention: resources (asthma kits including peak flow meter, MDI spacer device, plus educational materials), training of all health center staff in asthma care guidelines, and tools or templates for practice-level systems change (asthma flow sheets and standing orders). Control group sites received only copies of the national asthma guidelines. Chart reviews were performed to determine practitioner's compliance with national guidelines for asthma care. Clinicians practicing in intervention health centers showed significantly (p < 0.01) greater improvement on some measures than did the control health centers, although postintervention compliance with guidelines was still suboptimal. Disseminating national guidelines is not enough. Providing training and guideline-specific resources, in combination with tools for practice change, improved care significantly even in safety net health centers serving high-disparity patient populations.


Assuntos
Asma/terapia , Difusão de Inovações , Fidelidade a Diretrizes , Disseminação de Informação , Áreas de Pobreza , Atenção Primária à Saúde , Qualidade da Assistência à Saúde , Centros Comunitários de Saúde/economia , Educação , Financiamento Governamental , Fluxômetros , Pessoal de Saúde/educação , Acessibilidade aos Serviços de Saúde , Humanos , Inaladores Dosimetrados , Educação de Pacientes como Assunto/métodos , Guias de Prática Clínica como Assunto , Materiais de Ensino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA